rectogesic 4 mg/g rektalsalve
kyowa kirin holdings b.v. - glyceryltrinitrat - rektalsalve - 4 mg/g
dehydrobenzperidol 2,5 mg/ml injektionsvæske, opløsning
kyowa kirin holdings b.v. - droperidol - injektionsvæske, opløsning - 2,5 mg/ml
tostran 2 % gel
kyowa kirin holdings b.v. - testosteron - gel - 2 %
crysvita
kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - narkotika til behandling af knoglesygdomme - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.
moventig
kyowa kirin holdings b.v. - naloxegol oxalat - constipation; opioid-related disorders - perifere opioid-receptor-antagonister, medicin mod forstoppelse - behandling af opioidinduceret forstoppelse (oic) hos voksne patienter, som har haft utilstrækkelig respons på afføringsmiddel (er).
sancuso
kyowa kirin holdings b.v. - granisetron - vomiting; cancer - antiemetika og antinauseants, , serotonin (5ht3) antagonister - forebyggelse af kvalme og opkastning hos patienter, der modtager moderat eller stærkt emetogen kemoterapi, med eller uden cisplatin, i op til fem sammenhængende dage. sancuso kan anvendes i patienter, der modtager deres første kemoterapi eller patienter, der tidligere har modtaget kemoterapi.
abstral 100 mikrogram resoribletter, sublinguale
kyowa kirin holdings b.v. - fentanylcitrat - resoribletter, sublinguale - 100 mikrogram
abstral 200 mikrogram resoribletter, sublinguale
kyowa kirin holdings b.v. - fentanylcitrat - resoribletter, sublinguale - 200 mikrogram
abstral 300 mikrogram resoribletter, sublinguale
kyowa kirin holdings b.v. - fentanylcitrat - resoribletter, sublinguale - 300 mikrogram
abstral 400 mikrogram resoribletter, sublinguale
kyowa kirin holdings b.v. - fentanylcitrat - resoribletter, sublinguale - 400 mikrogram